These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8142661)

  • 81. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Management of allogeneic bone marrow transplant recipients at risk for cytomegalovirus disease using a surveillance bronchoscopy and prolonged pre-emptive ganciclovir therapy.
    Reddy V; Hao Y; Lipton J; Meharchand J; Minden M; Mazzulli T; Chan C; Messner HA
    J Clin Virol; 1999 Aug; 13(3):149-59. PubMed ID: 10443791
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy.
    Schapira L; Antin JH; Ransil BJ; Antman KH; Eder JP; McGarigle CJ; Goldberg MA
    Blood; 1990 Dec; 76(11):2354-9. PubMed ID: 2257306
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Samuel S; Kapelushnik J; Brautbar C; Or R
    Blood; 1996 Mar; 87(6):2195-204. PubMed ID: 8630379
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Cardiac surgery without homologous blood transfusion--the effectiveness and the indication of recombinant human erythropoietin].
    Watanabe Y; Fuse K; Naruse Y; Kobayashi T; Yamamoto S; Konishi H; Horii T
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):499-507. PubMed ID: 8035068
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion.
    Nakamura K; Inaba M; Sugiura K; Yoshimura T; Kwon AH; Kamiyama Y; Ikehara S
    Stem Cells; 2004; 22(2):125-34. PubMed ID: 14990852
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
    Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
    Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
    Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Feline bone marrow transplantation: its use in FIV-infected cats.
    Yamamoto JK; Pu R; Arai M; Pollock D; Irausquin R; Bova FJ; Fox LE; Homer BL; Gengozian N
    Vet Immunol Immunopathol; 1998 Oct; 65(2-4):323-51. PubMed ID: 9839883
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Compromising effect of low dose-rate total body irradiation on allogeneic bone marrow engraftment.
    van Os R; Konings AW; Down JD
    Int J Radiat Biol; 1993 Dec; 64(6):761-70. PubMed ID: 7903344
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Blood versus marrow hematopoietic allogeneic graft.
    Robinet E; Lapierre V; Tayebi H; Kuentz M; Blaise D; Tiberghien P
    Transfus Apher Sci; 2003 Aug; 29(1):53-9. PubMed ID: 12877895
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 98. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
    Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Perioperative use of allogenic blood components in live-related donor orthotopic liver transplantation: A cross sectional study.
    Pandey P; Tiwari AK; Sharma J; Srivastava D; Dixit S; Raina V
    Asian J Transfus Sci; 2013 Jan; 7(1):68-72. PubMed ID: 23559770
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Red eye and visual loss in a bone marrow transplant recipient.
    Corona-Lapuerta M; Martin-Moro F; Lario A; Pérez-Bañón MD; de Dios Caballero J; Fortún J; López J
    Ann Hematol; 2022 Jul; 101(7):1591-1592. PubMed ID: 35102485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.